High blood pressure and associated factors among HIV-infected young persons aged 13 to 25 years at selected health facilities in Rwenzori region, western Uganda, September–October 2021
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: High blood pressure (HBP), including hypertension (HTN), is a predictor of cardiovascular events, and is an emerging challenge in young persons. The risk of cardiovascular events may be further amplifed among people living with HIV (PLHIV). We determined the prevalence of HBP and associated factors among PLHIV aged 13 to 25 years in Rwenzori region, western Uganda. Methods: We conducted a cross-sectional study among PLHIV aged 13 to 25 years at nine health facilities in Kabarole and Kasese districts during September 16 to October 15, 2021. We reviewed medical records to obtain clinical and demographic data. At a single clinic visit, we measured and classifed BP as normal (<120/<80 mmHg), elevated (120/<80 to 129/<80), stage 1 HTN (130/80 to 139/89), and stage 2 HTN (≥140/90). We categorized participants as having HBP if they had elevated BP or HTN. We performed multivariable analysis using modifed Poisson regression to identify factors associated with HBP. Results: Of the 1,045 PLHIV, most (68%) were female and the mean age was 20 (3.8) years. The prevalence of HBP was 49% (n=515; 95% confdence interval [CI], 46%–52%), the prevalence of elevated BP was 22% (n=229; 95% CI, 26%–31%), and the prevalence of HTN was 27% (n=286; 95% CI, 25%–30%), including 220 (21%) with stage 1 HTN and 66 (6%) with stage 2 HTN. Older age (adjusted prevalence ratio [aPR], 1.21; 95% CI, 1.01–1.44 for age group of 18–25 years vs. 13–17 years), history of tobacco smoking (aPR, 1.41; 95% CI, 1.08–1.83), and higher resting heart rate (aPR, 1.15; 95% CI, 1.01–1.32 for>76 beats/min vs.≤76 beats/min) were associated with HBP. Conclusions: Nearly half of the PLHIV evaluated had HBP, and one-quarter had HTN. These fndings highlight a previously unknown high burden of HBP in this setting’s young populations. HBP was associated with older age, elevated resting heart rate, and ever smoking; all of which are known traditional risk factors for HBP in HIV-negative persons. To prevent future cardiovascular disease epidemics among PLHIV, there is a need to integrate HBP/HIV management.
Abstract
Background: High blood pressure (HBP), including hypertension (HTN), is a predictor of cardiovascular events, and is an emerging challenge in young persons. The risk of cardiovascular events may be further amplifed among people living with HIV (PLHIV). We determined the prevalence of HBP and associated factors among PLHIV aged 13 to 25 years in Rwenzori region, western Uganda. Methods: We conducted a cross-sectional study among PLHIV aged 13 to 25 years at nine health facilities in Kabarole and Kasese districts during September 16 to October 15, 2021. We reviewed medical records to obtain clinical and demographic data. At a single clinic visit, we measured and classifed BP as normal (<120/<80 mmHg), elevated (120/<80 to 129/<80), stage 1 HTN (130/80 to 139/89), and stage 2 HTN (≥140/90). We categorized participants as having HBP if they had elevated BP or HTN. We performed multivariable analysis using modifed Poisson regression to identify factors associated with HBP. Results: Of the 1,045 PLHIV, most (68%) were female and the mean age was 20 (3.8) years. The prevalence of HBP was 49% (n=515; 95% confdence interval [CI], 46%–52%), the prevalence of elevated BP was 22% (n=229; 95% CI, 26%–31%), and the prevalence of HTN was 27% (n=286; 95% CI, 25%–30%), including 220 (21%) with stage 1 HTN and 66 (6%) with stage 2 HTN. Older age (adjusted prevalence ratio [aPR], 1.21; 95% CI, 1.01–1.44 for age group of 18–25 years vs. 13–17 years), history of tobacco smoking (aPR, 1.41; 95% CI, 1.08–1.83), and higher resting heart rate (aPR, 1.15; 95% CI, 1.01–1.32 for>76 beats/min vs.≤76 beats/min) were associated with HBP. Conclusions: Nearly half of the PLHIV evaluated had HBP, and one-quarter had HTN. These fndings highlight a previously unknown high burden of HBP in this setting’s young populations. HBP was associated with older age, elevated resting heart rate, and ever smoking; all of which are known traditional risk factors for HBP in HIV-negative persons. To prevent future cardiovascular disease epidemics among PLHIV, there is a need to integrate HBP/HIV management.
참고문헌 (41)
- Triant VA, "Cardiovascular disease and HIV infection", Curr HIV, 2013, pp.10, 199~206
- Schutte AE, "Hypertension in low-and middle-income countries", Circ Res, 128, pp.808~826 (2021)
- Chen X, "Tracking of blood pressure from childhood to adulthood : a systematic review and meta-regression analysis", Circulation, 117, pp.3171~3180 (2008)
- Hinton TC, "Investigation and treatment of high blood pressure in young people : too much medicine or appropriate risk reduction?", Hypertension, 75, pp.16~22 (2020)
- Kayima J, "Determinants of hypertension in a young adult Ugandan population in epidemiological transition : the MEPI-CVD survey", BMC Public Health, 15, pp.830~ (2015)
- Triant VA, "HIV infection and coronary heart disease : an intersection of epidemics", J Infect Dis, 205(Suppl 3), pp.S355~S361 (2012)
- Armah KA, "Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and-uninfected veterans", Clin Infect Dis, 58, pp.121~129 (2014)
- Bourgi K, "Inflammation and metabolic complications in HIV", Curr HIV, 2018, pp.15, 371~381
- Collaboration ATC, "Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006 : collaborative analysis of 13 HIV cohort studies", Clin Infect Dis, 50, pp.1387~1396 (2010)
- Knudsen A, "Cardiovascular disease in patients with HIV", Future Virol, 7, pp.413~423 (2012)
- Fahme SA, "Hypertension in HIV-infected adults : novel pathophysiologic mechanisms", Hypertension, 72, pp.44~55 (2018)
- Matanje Mwagomba BL, "Opportunities and challenges for evidenceinformed HIV-noncommunicable disease integrated care policies and programs : lessons from Malawi, South Africa", Swaziland and Kenya AIDS, 32(Suppl 1), pp.S21~S32 (2018)
- "Consolidated Guidelines for Prevention and Treatment of HIV in Uganda |MOH Knowledge Management Portal"[URL]
- Kamkuemah M, "Missed opportunities for NCD multimorbidity prevention in adolescents and youth living with HIV in urban South Africa", BMC Public Health, 20, pp.821~ (2020)
- Kamkuemah M, "High prevalence of multimorbidity and non-communicable disease risk factors in South African adolescents and youth living with HIV : implications for integrated prevention", S Afr Med J, 112, pp.259~267 (2022)
- Chatterton-Kirchmeier S, "Increased prevalence of elevated blood pressures in HIV-infected children, adolescents and young adults", Pediatr Infect Dis J, 34, pp.610~614 (2015)
- Aronne LJ, "Classification of obesity and assessment of obesity related health risks", Obes Res, 10(S12), pp.105S~115S (2002)
- Flynn JT, "Clinical practice guideline for screening and management of high blood pressure in children and adolescents", Pediatrics, 140, pp.e20171904~ (2017)
- Barros AJ, "Alternatives for logistic regression in cross-sectional studies : an empirical comparison of models that directly estimate the prevalence ratio", BMC Med Res Methodol, 3, pp.21~ (2003)
- Nsanya MK, "Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda", J Clin Hypertens(Greenwich), 21, pp.470~478 (2019)
- Kidy F, "Blood pressure in primary school children in Uganda : a cross-sectional survey", BMC Public Health, 14, pp.1223~ (2014)
- Nkeh-Chungag BN, "Prevalence of hypertension and pre-hypertension in 13–17 year old adolescents living in Mthatha, South Africa : a cross-sectional study", Cent Eur J Public Health, 23, pp.59~64 (2015)
- Katamba G, "Prevalence of hypertension in relation to anthropometric indices among secondary adolescents in Mbarara", Southwestern Uganda Ital J Pediatr, 46, pp.76~ (2020)
- Jackson SL, "Hypertension among youths : United States, 2001–2016", MMWR Morb Mortal Wkly Rep, 67, pp.758~762 (2018)
- Mohsen IM, "Hypertension in developing countries : a major challenge for the future", Curr Hypertens Rep, 20, pp.38~ (2018)
- van Zoest RA, "Higher prevalence of hypertension in hiv-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure", Clin Infect Dis, 63, pp.205~213 (2016)
- Manner IW, "Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals", J Clin Hypertens(Greenwich), 15, pp.101~106 (2013)
- Xu Y, "The interaction between detectable plasma viral load and increased body mass index on hypertension among persons living with HIV", AIDS Care, 32, pp.890~895 (2020)
- Flack JM, "Blood pressure and the new ACC", AHA hypertension guidelines, 2020, pp.30, 160~164
- 김현창, "2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension", Clinical Hypertension, 25(4), pp.45~50 (2019), 대한고혈압학회[DOI]
- Liu Jing, "Highlights of the 2018 Chinese hypertension guidelines", Clinical Hypertension, 26(3), pp.20~25 (2020), 대한고혈압학회[DOI]
- Yun M, "Tobacco smoking strengthens the association of elevated blood pressure with arterial stiffness : the Bogalusa Heart Study", J Hypertens, 33, pp.266~274 (2015)
- Katamba G, "The utility of resting pulse rate in defining high blood pressure among adolescents in Mbarara municipality", Uganda J Hum Hypertens, 35, pp.1012~1019 (2021)
- Liu L, "Resting heart rate in relation to blood pressure : results from the world health organization-cardiovascular disease and alimentary comparison study", Int J Cardiol, 145, pp.73~74 (2010)
- Christofaro DG, "Relationship between resting heart rate, blood pressure and pulse pressure in adolescents", Arq Bras Cardiol, 108, pp.405~410 (2017)
- Cooney MT, "Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women", Am Heart J, 159, pp.612~619 (2010)
- Palatini P, "Elevated heart rate : a"new"cardiovascular risk factor?", Prog Cardiovasc Dis, 52, pp.1~5 (2009)
- Njuguna B, "Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa : lessons learned and evidence gaps", AIDS, 32(Suppl 1), pp.S33~S42 (2018)
- Pastakia SD, "Building reliable supply chains for noncommunicable disease commodities:lessons learned from HIV and evidence needs", AIDS, 32(Suppl 1), pp.S55~S61 (2018)
- Kwarisiima D, "Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study", BMC Public Health, 19, pp.511~ (2019)
- de Oliveira LM, "The number of visits and blood pressure measurements influence the prevalence of high blood pressure in adolescents", J Am Soc Hypertens, 11, pp.343~349 (2017)
